Tune in to this episode of "The Inside Track," a podcast series that examines the intersection of synthetic biology with capital markets and consumer products. Hosted by Jeff Buguliskis, Director of Content for SynbioBeta, this episode engages with Amanda Cashin, a Life Science Investor and Entrepreneur, and Erin Kim, Principal Owner of Erin Kim Consulting. The discussion focuses on the relationship between capital investment and the development of consumer products within the synthetic biology sector. They cover topics such as the growth of synthetic biology investments, the effects of economic conditions on capital flows, and recent innovations in consumer products. Additionally, the conversation includes insights on integrating consumer product innovation with capital investment, the influence of public perception, and the upcoming SynBioBeta conference. Join us for a detailed dialogue on the critical elements shaping the synthetic biology landscape.